BUDAPEST, Hungary, March 28, 2018 /PRNewswire/ --
The consolidated EBITDA for the Darholding companies rose sharplyby 57%, compared with previous year, partly as a result of our continuous reorganization efforts, while the consolidated revenue increased by 5% to EUR 9.6 million. As a recognition of our innovative stance, three EU grants
Darholding is a Budapest based upstream innovation incubating organization with interests in scientific research in pharmaceuticals, agrochemicals, fine chemicals, flavors and fragrances, laboratory instrumentation and chemistry development in Space. It operates globally through a network of companies who are all pioneers in their chosen field.
Contact: Gergely Darvas Investment Director Darholding Ltd firstname.lastname@example.org +36-1-880-8500
SOURCE Darholding Ltd.
Subscribe to our Free Newsletters!
Fallot's tetralogy is a rare and complex birth defect of the heart. Babies born with this condition ...
Bubonic plague is an infectious disease caused by the bacteria Yersinia pestis present in rodents ...
Steroids are miracle drugs but have to be used with caution. Some steroids are illegal to use, ...View All